Field Evaluation of a Simple Fluorescence Method for Detection of Viable Mycobacterium tuberculosis in Sputum Specimens during Treatment Follow-Up
Authors:
- 1 August 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (8) , 2788-2790
Abstract
Simple tuberculosis (TB) treatment monitoring tools are needed. We assessed the performance of fluorescein-diacetate (FDA) smear microscopy for detection of viable Mycobacterium tuberculosis in sputum specimens ( n = 288) of TB cases under treatment compared to culture (17.4% culture positivity). FDA sensitivity was moderate (83.7% [95% confidence interval {CI}, 70.3 to 92.6]), and specificity was low (66.1% [59.5 to 72.2]). The good negative predictive value (94.8% [90.1 to 97.8]) and negative likelihood ratio (0.2) suggest using this method to rule out treatment failure in settings without access to culture.Keywords
This publication has 7 references indexed in Scilit:
- Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB.2006
- Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.2002
- The Significance of the Persistent Presence of Acid-fast Bacilli in Sputum Smears in Pulmonary TuberculosisChest, 1999
- Incidence and Significance of Acid-fast Bacilli in Sputum Smears at the End of Antituberculous TreatmentChest, 1996
- [Application of FDA/EB staining for the detection of viable or non-viable mycobacteria in clinical specimens].1992
- Assessing the viability of Mycobacterium leprae by the fluorescein diacetate/ethidium bromide staining technique.1991
- ACID-FAST BACILLI IN SPUTUM SMEARS OF PATIENTS WITH PULMONARY TUBERCULOSIS - PREVALENCE AND SIGNIFICANCE OF NEGATIVE SMEARS PRETREATMENT AND POSITIVE SMEARS POST-TREATMENT1984